Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific (GOAL-ASIA)
Stephen Nicholls
2,000 participants
Sep 15, 2022
INTERVENTIONAL
Conditions
Summary
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study. Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.
Eligibility
Inclusion Criteria2
- years of age
- Admission for Type I myocardial infarction
Exclusion Criteria4
- LDL <1.4mmol/L at baseline
- Unable to provide contact details of primary care physician/general practitioner
- Unable to provide written informed consent.
- Unlikely to survive >12 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participant and clinician lipid score card to increase the likelihood of effecting guideline-directed change in lipid lowering therapy through two key actors - both the patient and their clinician(s). The Score Card documents four key fields to be completed by the participant, study team and participant's regular clinician including 1) 'current' LDL-C level, 2) participant's level of adherence to lipid-lowering therapy using modified Voil's criteria, 3) lipid-lowering management decisions made at the clinician's appointment and 4) currently prescribed lipid-lowering therapies.
Locations(22)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05325034